Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
30.26 USD | -1.51% | -4.00% | -10.34% |
10/05 | Pacira BioSciences Prices $250 Million Convertible Senior Notes Offering | MT |
08/05 | Needham Adjusts Price Target on Pacira BioSciences to $43 From $45, Keeps Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.34% | 142.99Cr | |
+38.33% | 72TCr | |
+34.28% | 59TCr | |
-4.34% | 37TCr | |
+20.23% | 33TCr | |
+2.44% | 28TCr | |
+17.02% | 24TCr | |
+9.31% | 21TCr | |
-5.07% | 21TCr | |
+0.04% | 17TCr |
- Stock Market
- Equities
- PCRX Stock
- News Pacira BioSciences, Inc.
- Insider Sell: Pacira BioSciences